Transcriptomic Analysis of Identical Twins with Different Onset Ages of Adrenoleukodystrophy

Qiuyu Su, Yinglian Chen, Chuhua Fu, Yonghui Zhang, Yan Zhang, Ying Cao, Xinggang Wang, Zhiming Zeng, Chen Liu, Yang Zhao, Changlin Yin, Liang TanResearch Square 2024 · DOI

Abstract

Adrenoleukodystrophy (ALD) is a rare X-linked neurogenetic disease caused by mutations in the ABCD1 gene. Currently, the molecular mechanisms underlying the onset and severity of ALD still remain unclear. This study aimed to identify candidate genes associated with the onset and severity of ALD by performing transcriptome sequencing on whole blood samples from a family of monozygotic twins. By identifying differentially expressed genes (DEGs), performing set theory analysis, and gene enrichment analysis, researchers identified potential candidate genes. Five distinct sets of DEGs were identified from a family of identical twins with different onset ages and ABCD1 exon 2 deletion. Specifically, 39 DEGs and 425 DEGs were linked to the onset and severity of ALD. Key genes identified include C4BPA, TPBG, CEP112, CHST15, SMAD1, IL-26, and LRRC69. Enrichment analysis suggested the roles of Ca2+ homeostasis and plasma membrane stability in disease progression.

Introduction

X-linked adrenoleukodystrophy (ALD) is a devastating neurogenetic disorder triggered by mutations in the ABCD1 gene. This genetic defect leads to the accumulation of very long-chain fatty acids (VLCFAs), which destroy the myelin sheath of nerves and damage the adrenal glands. A significant challenge in treating ALD is the "phenotype-genotype gap": individuals with the exact same ABCD1 mutation can exhibit vastly different clinical outcomes, ranging from asymptomatic adulthood to rapid childhood cerebral decline. This study investigates modifier genes that may influence these divergent paths using a unique twin-based model.

Study Design and Methods

The researchers utilized a "natural experiment" by studying a single family that included identical twins with the same genetic mutation but different clinical presentations. The cohort consisted of eight individuals, including symptomatic and asymptomatic carriers, as well as healthy controls.

Table 1: Clinical characteristics and classifications of the eight study participants.

To isolate the genetic signals responsible for disease onset, the team performed whole-blood transcriptome sequencing (RNA-seq). They employed set theory analysis to compare gene expression across five distinct groups to identify unique intersections of activity.

Table 2: Comparative groups used for identifying differentially expressed gene (DEG) sets.

Key Insights and Results

By comparing the symptomatic twin against healthy controls and asymptomatic carriers, the researchers narrowed thousands of genes down to seven high-priority candidates: C4BPA, TPBG, CEP112, CHST15, SMAD1, IL-26, and LRRC69.

Calcium Homeostasis and Membrane Stability

Gene Ontology (GO) and KEGG pathway enrichment analysis highlighted two critical biological areas: calcium (Ca2+) homeostasis and plasma membrane stability. Because VLCFA accumulation is known to destabilize membranes, these findings suggest that a patient's ability to maintain calcium balance under membrane stress may determine whether they remain asymptomatic or develop symptoms.

Immune System Involvement

Several of the identified genes, such as IL-26 and C4BPA, are linked to inflammation and the complement system. This reinforces the understanding of ALD as not just a metabolic disorder, but an active neuroinflammatory process.

Conclusion and Future Directions

This preliminary exploration identifies a specific set of 425 genes linked to the transition from an asymptomatic to an "illness" state. While the small sample size (one family) is a limitation, the identical twin model provides a powerful control for genetic background. Future research will focus on validating these seven candidate genes in larger cohorts and using functional assays to confirm their roles in ALD pathogenesis. These findings offer novel insights into the molecular mechanisms of ALD and potential targets for mitigating disease development.

Summary updated

Abstract

<title>Abstract</title> Adrenoleukodystrophy (ALD) is a rare X-linked neurogenetic disease caused by mutations in the <italic>ABCD1</italic> gene. Currently, the molecular mechanisms underlying the onset and severity of ALD still remain unclear. Therefore, the aim of this paper is to mine information on candidate genes associated with onset and severity of ALD by transcriptome sequencing of whole blood samples from monozygotic twin families with ALD disease.<bold> </bold>The identifying of differentially expressed genes (DEGs), set theory analysis, gene enrichment analysis, and classification statistics of expression trend had been executed to identify potential candidate genes inducing the onset and severity of ALD in patients. And, eight ALD patients, which constituted by two normal children, two ALD child twins, twins’ mother, twins’ adult uncle with ALD, twins’ grandmother, and a normal adult had been used.<bold> </bold>In the present, five distinct sets of differentially expressed genes (DEGs) were identified via using whole blood samples from a family of identical twins with different onset ages and <italic>ABCD1</italic> exon 2 deletion. Then, 39 DEGs of A∩B∩C-D and A∩B-D as well as 425 DEGs of C∩E had been considered as relating genes with the onset and severity of ALD. Especially, <italic>C4BPA, TPBG, CEP112, CHST15, SMAD1, IL-26, </italic>and<italic> LRRC69</italic> had shown more important than others about ALD onset. Meanwhile, KEGG and GO enrichment further suggested the role of Ca<sup>2+</sup> homeostasis and plasma membrane for ALD onset and severity. Finally, expression pattern analysis further demonstrated the pivotal role of the selected DEG sets. The information on candidate genes of this research had been considered as the crucial for preliminarily exploring the molecular mechanisms relating to the onset and severity of ALD, which offered novel insights and research directions for mitigating and treating the development of ALD.
BibTeX
@inproceedings{su2024transcriptomic,
  author = {Qiuyu Su and Yinglian Chen and Chuhua Fu and Yonghui Zhang and Yan Zhang and Ying Cao and Xinggang Wang and Zhiming Zeng and Chen Liu and Yang Zhao and Changlin Yin and Liang Tan},
  title = {{Transcriptomic Analysis of Identical Twins with Different Onset Ages of Adrenoleukodystrophy}},
  booktitle = {Research Square},
  year = {2024},
  doi = {10.21203/rs.3.rs-5336514/v1},
}
Figure